organophosphonates has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantemir-Stone, CZ; Deodhar, M; Findlay, AD; Jarolimek, W; Leksa, V; Marsh, CB; Molloy, M; Ohradanova-Repic, A; Schilter, H; Song, X; Stockinger, H | 1 |
| Aidinis, V; Bouros, D; Kaffe, E; Karameris, A; Mouratis, MA; Oikonomou, N; Prestwich, GD; Tzouvelekis, A; Valavanis, C; Vilaras, G | 1 |
2 other study(ies) available for organophosphonates and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
Topics: Actins; Airway Remodeling; Animals; Biological Availability; Biomarkers; Cell Line; Collagen; Fibroblasts; Fibronectins; Humans; Idiopathic Pulmonary Fibrosis; Insulin-Like Growth Factor II; Lung; Mannosephosphates; Mannosides; Mice; Mice, Knockout; Organophosphonates; Prodrugs; Proteomics; Signal Transduction; Tenascin; Transforming Growth Factor beta1 | 2015 |
Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.
Topics: Adult; Aged; Anilides; Animals; Bronchoalveolar Lavage Fluid; Female; Gene Expression; Gene Knockout Techniques; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lysophospholipids; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Organophosphonates; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Respiratory Mucosa | 2012 |